221 related articles for article (PubMed ID: 20435780)
21. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. Surveillance study.
Jacobs MR; Bajaksouzian S; Zilles A; Lin G; Pankuch GA; Appelbaum PC
Antimicrob Agents Chemother; 1999 Aug; 43(8):1901-8. PubMed ID: 10428910
[TBL] [Abstract][Full Text] [Related]
22. Ocular pharmacokinetics/pharmacodynamics of besifloxacin, moxifloxacin, and gatifloxacin following topical administration to pigmented rabbits.
Proksch JW; Ward KW
J Ocul Pharmacol Ther; 2010 Oct; 26(5):449-58. PubMed ID: 20874668
[TBL] [Abstract][Full Text] [Related]
23. Activities and postantibiotic effects of gemifloxacin compared to those of 11 other agents against Haemophilus influenzae and Moraxella catarrhalis.
Davies TA; Kelly LM; Hoellman DB; Ednie LM; Clark CL; Bajaksouzian S; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2000 Mar; 44(3):633-9. PubMed ID: 10681330
[TBL] [Abstract][Full Text] [Related]
24. Besifloxacin: A Critical Review of Its Characteristics, Properties, and Analytical Methods.
Tótoli EG; Salgado HRN
Crit Rev Anal Chem; 2018 Mar; 48(2):132-142. PubMed ID: 29345957
[TBL] [Abstract][Full Text] [Related]
25. Speed of bacterial kill with a fluoroquinolone compared with nonfluoroquinolones: clinical implications and a review of kinetics of kill studies.
Lichtenstein SJ; Wagner RS; Jamison T; Bell B; Stroman DW
Adv Ther; 2007; 24(5):1098-111. PubMed ID: 18029337
[TBL] [Abstract][Full Text] [Related]
26. Antibiotic Resistance Among Ocular Pathogens in the United States: Five-Year Results From the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) Surveillance Study.
Asbell PA; Sanfilippo CM; Pillar CM; DeCory HH; Sahm DF; Morris TW
JAMA Ophthalmol; 2015 Dec; 133(12):1445-54. PubMed ID: 26502312
[TBL] [Abstract][Full Text] [Related]
27. AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States.
Pfaller MA; Farrell DJ; Sader HS; Jones RN
Clin Infect Dis; 2012 Sep; 55 Suppl 3():S187-93. PubMed ID: 22903951
[TBL] [Abstract][Full Text] [Related]
28. In vitro antibacterial activity of AZD0914, a new spiropyrimidinetrione DNA gyrase/topoisomerase inhibitor with potent activity against Gram-positive, fastidious Gram-Negative, and atypical bacteria.
Huband MD; Bradford PA; Otterson LG; Basarab GS; Kutschke AC; Giacobbe RA; Patey SA; Alm RA; Johnstone MR; Potter ME; Miller PF; Mueller JP
Antimicrob Agents Chemother; 2015 Jan; 59(1):467-74. PubMed ID: 25385112
[TBL] [Abstract][Full Text] [Related]
29.
Mohamed NM; Zakaria AS; Edward EA; Abdel-Bary A
Pol J Microbiol; 2019; 68(1):59-69. PubMed ID: 31050254
[TBL] [Abstract][Full Text] [Related]
30. Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Greece.
Torumkuney D; Papaparaskevas J; Morrissey I
J Antimicrob Chemother; 2018 Apr; 73(suppl_5):v36-v42. PubMed ID: 29659884
[TBL] [Abstract][Full Text] [Related]
31. The pharmacodynamic properties of azithromycin in a kinetics-of-kill model and implications for bacterial conjunctivitis treatment.
Dorfman MS; Wagner RS; Jamison T; Bell B; Stroman DW
Adv Ther; 2008 Mar; 25(3):208-17. PubMed ID: 18369536
[TBL] [Abstract][Full Text] [Related]
32. Susceptibility of Canadian isolates of Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pneumoniae to oral antimicrobial agents.
Blondeau JM; Vaughan D; Laskowski R; Borsos S;
Int J Antimicrob Agents; 2001 Jun; 17(6):457-64. PubMed ID: 11397615
[TBL] [Abstract][Full Text] [Related]
33. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from class B hospitals in China during 2013 and 2014].
Sun H; Chen L; Chen X; Jia X; Li N; Liu W; Tong H; Xiang R; Zhang F; Zhao H; Zhang J; Xu Y
Zhonghua Jie He He Hu Xi Za Zhi; 2016 Jan; 39(1):30-7. PubMed ID: 26792053
[TBL] [Abstract][Full Text] [Related]
34. Pharmacodynamic activity of garenoxacin against ciprofloxacin-resistant Streptococcus pneumoniae.
Zhanel GG; James J; Derkatch S; Laing N; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2006 Jul; 58(1):112-6. PubMed ID: 16644764
[TBL] [Abstract][Full Text] [Related]
35. Kinetic bactericidal activity of telithromycin, azithromycin and clarithromycin against respiratory pathogens.
Drago L; De Vecchi E; Nicola L; Legnani D; Gismondo MR
APMIS; 2005 Oct; 113(10):655-63. PubMed ID: 16309423
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis.
McDonald MB; Protzko EE; Brunner LS; Morris TW; Haas W; Paterno MR; Comstock TL; Usner DW
Ophthalmology; 2009 Sep; 116(9):1615-1623.e1. PubMed ID: 19643483
[TBL] [Abstract][Full Text] [Related]
37. Susceptibility of European respiratory tract isolates to trovafloxacin, ciprofloxacin, clarithromycin, azithromycin and ampicillin.
Pontani D; Washton H; Bouchillon S; Johnson J
Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):413-9. PubMed ID: 9758284
[TBL] [Abstract][Full Text] [Related]
38. In vitro activities of novel nonfluorinated quinolones PGE 9262932 and PGE 9509924 against clinical isolates of Staphylococcus aureus and Streptococcus pneumoniae with defined mutations in DNA gyrase and topoisomerase IV.
Jones ME; Critchley IA; Karlowsky JA; Blosser-Middleton RS; Schmitz FJ; Thornsberry C; Sahm DF
Antimicrob Agents Chemother; 2002 Jun; 46(6):1651-7. PubMed ID: 12019071
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial activity of DC-159a, a new fluoroquinolone, against 1,149 recently collected clinical isolates.
Jones RN; Fritsche TR; Sader HS
Antimicrob Agents Chemother; 2008 Oct; 52(10):3763-75. PubMed ID: 18573936
[TBL] [Abstract][Full Text] [Related]
40.
Honda H; Sato T; Shinagawa M; Fukushima Y; Nakajima C; Suzuki Y; Kuronuma K; Takahashi S; Takahashi H; Yokota SI
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31740553
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
